Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC-Reference-Cited by-同舟云学术

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Published:2018-09 Issue:9 Volume:13 Page:1248-1268
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Rolfo Christian,Mack Philip C.,Scagliotti Giorgio V.,Baas Paul,Barlesi Fabrice,Bivona Trever G.,Herbst Roy S.,Mok Tony S.,Peled Nir,Pirker Robert,Raez Luis E.,Reck Martin,Riess Jonathan W.,Sequist Lecia V.,Shepherd Frances A.,Sholl Lynette M.,Tan Daniel S.W.,Wakelee Heather A.,Wistuba Ignacio I.,Wynes Murry W.,Carbone David P.,Hirsch Fred R.,Gandara David R.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference140 articles.

1. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

2. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations;Sequist;J Clin Oncol,2013

3. Osimertinib in pretreated T790M-positive advanced non–small-cell lung cancer: AURA study phase II extension component;Yang;J Clin Oncol,2017

4. AZD9291 in EGFR inhibitor-resistant non–small-cell lung cancer;Janne;N Engl J Med,2015

5. Osimertinib for pretreated EGFR Thr790Met-positive advanced non–small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study;Goss;Lancet Oncol,2016

Cited by 529 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

2. Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC);Clinical Oncology;2024-10

3. ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance;JTO Clinical and Research Reports;2024-09

4. Advances and future directions in ROS1 fusion-positive lung cancer;The Oncologist;2024-08-23

5. Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis;Molecular Diagnosis & Therapy;2024-08-02